CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · Science & Nature

SHP099

chemical compound

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 20, 2026
Entity authorityQ27455906 ↗
Source-derived summary

SHP099 is a drug that acts as an inhibitor of the protein tyrosine phosphatase enzyme SHP-2 (PTPN11). It was developed as a potential agent for the treatment of cancer, but while it is potent, orally active and effective at inhibiting SHP-2 activity and slowing tumor growth, it was not developed for clinical use because of dose-limiting side effects. However it continues to be widely used in cancer research and a number of related derivatives have been developed. It has also been used to research the role of SHP-2 in other processes such as regulation of bone growth during development.

Editorial summary

“SHP099” enters the record as chemical compound. Crown Archives preserves that source wording while asking what SHP099, chemical and compound can confirm, complicate or overturn.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current 99-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its strongest next move is a source search built around SHP099, chemical and compound.
Editorial analysis

Why this record matters

“SHP099” is worth following because a concise public description often conceals a longer documentary argument. Here, SHP099, chemical and compound provides the most credible route into that argument.

Evidence profile

Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Aug 20, 2026. The linked authority identifier is Q27455906.

Critical limits

A general summary may omit uncertainty, sample limits or methodological disagreement that is explicit in the technical record. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “SHP099”, its source revision and the description used here.
  2. Expand the search: follow SHP099 primary sources, SHP099 archive and SHP099 research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “SHP099”?
  2. Which observation, specimen, dataset or publication supports the account?
  3. Has classification or technical consensus changed since the cited source?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “SHP099” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.